Actionable news
All posts from Actionable news
Actionable news in CLVS: Clovis Oncology, Inc.,

Biotech: Why Clovis And Tesaro Look Well Positioned

Morgan Stanley's Andrew Berens and his team have a note out on biotech, writing that investors should buy Clovis Oncology (CLVS) and Tesaro (TSRO) ahead of any labeling decision by the Food and Drug...